This inventor holds 2 USPTO granted patents. Top assignee: Harvard College. Active years: 2003-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003-2004
Title: Dario A A Vignali: Innovator in Immunomodulatory Peptides
Introduction
Dario A A Vignali is a prominent inventor based in Rainham, GB. He has made significant contributions to the field of immunology, particularly through his work on immunomodulatory peptides. With a total of 2 patents to his name, Vignali's research has the potential to impact therapeutic approaches in various medical conditions.
Latest Patents
Vignali's latest patents focus on immunomodulatory peptides. The first patent describes a purified preparation of a peptide consisting essentially of an amino acid sequence identical to that of a segment of a naturally-occurring human protein. This segment is between 10 to 30 residues in length and binds to a human major histocompatibility complex (MHC) class II allotype. The second patent is identical in description, emphasizing the importance of this peptide in immunological applications.
Career Highlights
Dario A A Vignali is affiliated with Harvard College, where he conducts his research. His work has garnered attention for its innovative approach to understanding immune responses and developing new therapeutic strategies.
Collaborations
Vignali has collaborated with notable colleagues, including Robert Glen Urban and Roman M Chicz. These collaborations have further enriched his research and contributed to advancements in the field.
Conclusion
Dario A A Vignali is a key figure in the development of immunomodulatory peptides, with a focus on enhancing our understanding of immune mechanisms. His contributions are paving the way for future innovations in immunotherapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile